Erianin mitigates diabetic cardiomyopathy via adenosine monophosphate-activated protein kinase-nuclear factor erythroid 2-related factor 2-heme oxygenase-1 pathway activation

Figure 7 Comparison of malondialdehyde contents and superoxide dismutase and catalase activities in mice with type 2 diabetes mellitus. A: Malondialdehyde; B: Superoxide dismutase; C: Catalase. Bar charts represent the mean ± SEM, n = 8. ^cP < 0.001 vs control group; ^dP < 0.05 vs model group; ^eP < 0.01 vs model group; ^fP < 0.001 vs model group; MDA: Malondialdehyde; SOD: Superoxide dismutase; CAT: Catalase.